![Joshua S. Salafsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joshua S. Salafsky
Keine laufenden Positionen mehr
Karriereverlauf von Joshua S. Salafsky
Ehemalige bekannte Positionen von Joshua S. Salafsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BlueLight Therapeutics, Inc.
![]() BlueLight Therapeutics, Inc. BiotechnologyHealth Technology BlueLight Therapeutics, Inc. develops novel systems to analyze real-time protein function for research and clinical applications. The firm offers technology for detecting conformational change in proteins and other biological molecules. Its technology is based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time and since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how the body functions and respond to treatments. The company was founded by Joshua S. Salafsky and Greg S. Yap in 2013 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 29.10.2013 | 10.09.2018 |
Technik-/Wissenschafts-/F&E-Leiter | 18.10.2013 | 10.09.2018 | |
Gründer | 01.01.2013 | 10.09.2018 |
Ausbildung von Joshua S. Salafsky
Stanford University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
BlueLight Therapeutics, Inc.
![]() BlueLight Therapeutics, Inc. BiotechnologyHealth Technology BlueLight Therapeutics, Inc. develops novel systems to analyze real-time protein function for research and clinical applications. The firm offers technology for detecting conformational change in proteins and other biological molecules. Its technology is based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time and since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how the body functions and respond to treatments. The company was founded by Joshua S. Salafsky and Greg S. Yap in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Joshua S. Salafsky
- Erfahrung